Stay updated on Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedLocations sections were added with California, New Jersey, and New York sites, and the revision version updated to v3.3.3. The previous Location headings (California Locations, New Jersey Locations, New York Locations) were removed, and the HHS Vulnerability Disclosure link was deleted.SummaryDifference0.4%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check53 days agoChange DetectedRemoved the government funding notice that previously appeared on the page. The core study information and eligibility criteria remain unchanged.SummaryDifference0.4%

- Check67 days agoChange DetectedStudy Details page appears unchanged in terms of title, conditions, eligibility, and locations. Any observed differences are limited to formatting or display.SummaryDifference0.4%

- Check95 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%

- Check102 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.